ArticleInternational journal of molecular sciences2026
Baloxavir Exhibits Antibacterial Activity Against
Xue Li, Yan Yang, Penghe Wang, Tongying Nie, Xinxin Hu, Xuefu You, Xiukun Wang, Congran Li
Abstract read
In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Xue LiBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Yan YangMedical Research Center, The Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu 610031, China.
Penghe WangBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Tongying NieBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Xinxin HuBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Xuefu YouBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.ORCID 0000-0003-2156-1408 Xiukun WangBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Congran LiBeijing Key Laboratory of Technology and Application for Anti-Infective New Drugs Research and Development, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Funding
CAMS Innovation Fund for Medical Sciences 2023-I2M-2-006; 2021-I2M-1-039Medical Research Project of Chengdu 2025033National Key Research and Development Program of China 2024YFC2309300National Science and Technology Infrastructure of China NPRC-32
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Anti-Bacterial AgentsDibenzothiepinsMorpholinesPurinesPyridinesPyridonesStaphylococcal InfectionsStaphylococcus aureusThiepinsTriazinesA549 CellsAmidesAnimalsHumansMethicillin-Resistant Staphylococcus aureusMiceAmidesAnti-Bacterial AgentsbaloxavirDibenzothiepinsMorpholinespurinePurinesPyridinesPyridonesThiepinsTriazinesantibacterialbaloxavirintracellularpurine biosynthesisStaphylococcus aureus
Identifiers
PMID42123476
PMCPMC13163285
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390